Binhui Ren
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Glycosylation and Glycoproteins Research
Papers in
-
- Cancer-related molecular mechanisms research 7
- Cancer, Hypoxia, and Metabolism 3
- MicroRNA in disease regulation 3
- Cancer Genomics and Diagnostics 2
-
- RNA modifications and cancer 11
- Epigenetics and DNA Methylation 5
- Glycosylation and Glycoproteins Research 3
- Co-authors
- Lin Xu (9 shared papers)Juncheng Dai (2 shared papers)Qi Sun (7 shared papers)Zhibin Hu (2 shared papers)Yang Chen (1 shared paper)Longbang Chen (1 shared paper)Jicheng Xing (1 shared paper)Junjun Wang (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)Cancer Letters (2 papers)Frontiers in Oncology (2 papers)OncoTargets and Therapy (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesBrazil
In The Last Decade
Binhui Ren
32 papers receiving 912 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 382
- Molecular Biology 488
- Hematology 51
- Oncology 110
- Immunology 82
Countries citing papers authored by Binhui Ren
This map shows the geographic impact of Binhui Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binhui Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binhui Ren more than expected).
Fields of papers citing papers by Binhui Ren
This network shows the impact of papers produced by Binhui Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binhui Ren. The network helps show where Binhui Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Binhui Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 272 | |
| 2 | 2006 | 61 | |
| 3 | 2019 | 44 | |
| 4 | 2022 | 40 | |
| 5 | 2017 | 36 | |
| 6 | 2012 | 36 | |
| 7 | 2021 | 33 | |
| 8 | 2006 | 32 | |
| 9 | 2016 | 30 | |
| 10 | Clinicopathological and prognostic significance of MUC4 expression in cancers: evidence from meta-analysis. | 2015 | 27 |
| 11 | 2016 | 27 | |
| 12 | 2018 | 26 | |
| 13 | 2017 | 24 | |
| 14 | 2016 | 23 | |
| 15 | 2015 | 22 | |
| 16 | 2011 | 20 | |
| 17 | 2016 | 20 | |
| 18 | 2019 | 18 | |
| 19 | 2024 | 18 | |
| 20 | 2017 | 16 |
About Binhui Ren
Binhui Ren is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Cell Biology, having authored 36 papers that have together received 922 indexed citations. Recurring topics across this work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (7 papers), Epigenetics and DNA Methylation (5 papers), Glycosylation and Glycoproteins Research (3 papers), Ferroptosis and cancer prognosis (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), MicroRNA in disease regulation (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (382 citations), Molecular Biology (488 citations), Hematology (51 citations), Oncology (110 citations) and Immunology (82 citations). Binhui Ren has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Lin Xu, Juncheng Dai, Qi Sun, Zhibin Hu, Yang Chen, Longbang Chen, Jicheng Xing, Junjun Wang, Ke Zen and Cheng Wang. Their work appears in journals such as Biochemical and Biophysical Research Communications, Cancer Letters, Frontiers in Oncology, OncoTargets and Therapy and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.